Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Canadian Employer Plans Covering GLP-1s for Weight Loss Have Nearly Doubled Data from the International Foundation of Employee Benefit Plans (IFEBP) 2025 Pulse Survey shows a significant shift in Canadian employer attitudes toward GLP-1 coverage: 31% of employer plans now cover GLP-1s for weight loss (up from 17% in 2024) 56% cover for diabetes only (down from 66% in 2024) 20% of diabetes-only plans are considering adding obesity coverage Provincial public drug plans still cover semaglutide only for type 2 diabetes not for weight loss
However, understanding the long-term stability of that weight loss and how it fluctuates is critical for healthcare providers and patients alike
Read clinical review Questions Ozempic and Finasteride Interaction: What Prescribers and Patients Should Know A clinical review of the drug interaction profile between Ozempic (semaglutide 0.5 to 2.0 mg) and finasteride, covering pharmacokinetic and pharmacodynamic considerations, monitoring, and dose-adjustment guidance
The product itself is top tier
Be aware that excessive consumption of sugar alcohols (often found in sugar-free products) may worsen diarrhoea in some people
The global epidemic of the metabolic syndrome
US$ 25.06
US$ 29.22
US$ 27.09
US$ 25.78
